Exclusive

Publication

Byline

Location

US Patent Issued to LG CHEM on Aug. 4 for "Benzimidazole-substituted fluoranthene compound, and organic light emitting device including the same" (South Korean Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,274, issued on Aug. 4, was assigned to LG CHEM Ltd. (Seoul, South Korea). "Benzimidazole-substituted fluoranthene compound, and organic ligh... Read More


US Patent Issued to SAMSUNG SDI on Aug. 4 for "Compound for organic optoelectronic device, composition for organic optoelectronic device, organic optoelectronic device and display device" (South Korean Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,275, issued on Aug. 4, was assigned to SAMSUNG SDI Co. LTD. (Yongin-si, South Korea). "Compound for organic optoelectronic device, compositi... Read More


US Patent Issued to University of Notre Dame du Lac on Aug. 4 for "Antibacterial picolinamide compounds" (Indiana Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,276, issued on Aug. 4, was assigned to University of Notre Dame du Lac (South Bend, Ind.). "Antibacterial picolinamide compounds" was invent... Read More


US Patent Issued to ZHEJIANG UNIVERSITY, SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES on Aug. 4 for "2-polysubstituted aromatic ring-pyrimidine derivatives, preparation and medical application thereof" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,277, issued on Aug. 4, was assigned to ZHEJIANG UNIVERSITY (Hangzhou, China) and SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCI... Read More


US Patent Issued to AVELOS THERAPEUTICS on Aug. 4 for "Preparation of substituted 1,2-diaminoheterocyclic compound derivatives and their use as pharmaceutical agents" (South Korean, British, Swedish, Italian Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,278, issued on Aug. 4, was assigned to AVELOS THERAPEUTICS INC. (Seoul, South Korea). "Preparation of substituted 1,2-diaminoheterocyclic co... Read More


US Patent Issued to PHARMNOVO on Aug. 4 for "Polymorphs of a hydrochloride salt of PN6047" (Swedish Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,279, issued on Aug. 4, was assigned to PHARMNOVO AB (Lund, Sweden). "Polymorphs of a hydrochloride salt of PN6047" was invented by Bengt Von... Read More


US Patent Issued to Interdict Bio on Aug. 4 for "Small molecule protein synthesis modulators" (California Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,280, issued on Aug. 4, was assigned to Interdict Bio Inc. (South San Francisco, Calif.). "Small molecule protein synthesis modulators" was i... Read More


US Patent Issued on Aug. 4 for "Thiazole derivatives for therapeutic use" (Virginia Inventor)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,281, issued on Aug. 4. "Thiazole derivatives for therapeutic use" was invented by Josep Bassaganya-Riera (Blacksburg, Va.). According to th... Read More


US Patent Issued to AstraZeneca on Aug. 4 for "Inhibitors of myeloperoxidase" (Swedish Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,282, issued on Aug. 4, was assigned to AstraZeneca AB (Sodertalje, Sweden). "Inhibitors of myeloperoxidase" was invented by Tord Inghardt (S... Read More


US Patent Issued to vTv Therapeutics on Aug. 4 for "Quinoline derivatives, pharmaceutically acceptable salts, and methods of use thereof" (Maryland Inventor)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,283, issued on Aug. 4, was assigned to vTv Therapeutics LLC (High Point, N.C.). "Quinoline derivatives, pharmaceutically acceptable salts, a... Read More